[Effects of the new adrenergic beta receptor blockader Kö 1366 (Bunitrolol) on blood circulation].
D000293:Adolescent; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000328:Adult; D000818:Animals; D001281:Atrial Fibrillation / Q000503:physiopathology; D001794:Blood Pressure / Q000187:drug effects; D002082:Butylamines / Q000494:pharmacology; D002200:Capillary Resistance / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D003864:Depression, Chemical; D004285:Dogs; D004562:Electrocardiography; D005260:Female; D006168:Guinea Pigs; D006331:Heart Diseases / Q000503:physiopathology; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009570:Nitriles / Q000494:pharmacology; D005082:Physical Exertion; D010991:Plethysmography; D011412:Propanolamines / Q000494:pharmacology*; D011433:Propranolol / Q000494:pharmacology; D011651:Pulmonary Artery / Q000187:drug effects; D013610:Tachycardia / Q000503:physiopathology
D000319:Adrenergic beta-Antagonists; D002082:Butylamines; D009570:Nitriles; D011412:Propanolamines; D011433:Propranolol
Kreislaufwirkungen des neuen beta-Rezeptorenblockers Kö 1366 (Bunitrolol.